Skip to content
PubMed This is a summary of 91 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 91 referenced papers

Top Authors

Oskar Hansson
Lund University
Henrik Zetterberg
University of Wisconsin–Madison
Adam L. Boxer
University Memory and Aging Center
Rik Ossenkoppele
Amsterdam Neuroscience
Gil D. Rabinovici
University of California, San Francisco
Jonathan D. Rohrer
Mayo Clinic in Arizona
Kaj Blennow
Sahlgrenska University Hospital
Agustín Ibáñez
Adolfo Ibáñez University
Bruce L. Miller
Baycrest Hospital
Clifford R. Jack
Mayo Clinic

Top Institutions

Ranked by publications Top 10 institutions

References

References (91)
  1. 1

    Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations.

    Lashley T, Rohrer JD, Mead S, Revesz T

    Neuropathology and applied neurobiology 2015; (41(7)):858-81 doi:10.1111/nan.12250.

    PMID: 26041104
  2. 2

    Enhancing caregivers' understanding of dementia and tailoring activities in frontotemporal dementia: two case studies.

    O'Connor CM, Clemson L, Brodaty H, et al.

    Disability and rehabilitation 2016; (38(7)):704-14 doi:10.3109/09638288.2015.1055375.

    PMID: 26056858
  3. 3

    The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

    Ossenkoppele R, Pijnenburg YA, Perry DC, et al.

    Brain : a journal of neurology 2015; (138(Pt 9)):2732-49 doi:10.1093/brain/awv191.

    PMID: 26141491
  4. 4

    Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral Sclerosis.

    Woolley SC, Strong MJ

    Neurologic clinics 2015; (33(4)):787-805.

    PMID: 26515622
  5. 5

    Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis.

    Kansal K, Mareddy M, Sloane KL, et al.

    Dementia and geriatric cognitive disorders 2016; (41(1-2)):109-22 doi:10.1159/000443205.

    PMID: 26854827
  6. 6

    TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation.

    Ishiguro A, Kimura N, Watanabe Y, et al.

    Genes to cells : devoted to molecular & cellular mechanisms 2016; (21(5)):466-81 doi:10.1111/gtc.12352.

    PMID: 26915990
  7. 7

    Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features.

    Rogalski E, Sridhar J, Rader B, et al.

    Neurology 2016; (87(13)):1337-43 doi:10.1212/WNL.0000000000003165.

    PMID: 27566743
  8. 8

    Amyloid Imaging: Poised for Integration into Medical Practice.

    Anand K, Sabbagh M

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2017; (14(1)):54-61 doi:10.1007/s13311-016-0474-y.

    PMID: 27571940
  9. 9

    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.

    Arroyo-Anlló EM, Bouston AT, Fargeau MN, et al.

    Journal of Alzheimer's disease : JAD 2017; (55(4)):1437-1443 doi:10.3233/JAD-160770.

    PMID: 27858712
  10. 10

    Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.

    Buoli M, Serati M, Caldiroli A, et al.

    Journal of geriatric psychiatry and neurology 2017; (30(3)):162-169 doi:10.1177/0891988717700506.

    PMID: 28351199
  11. 11

    Atypical parkinsonian syndromes: a general neurologist's perspective.

    Deutschländer AB, Ross OA, Dickson DW, Wszolek ZK

    European journal of neurology 2018; (25(1)):41-58 doi:10.1111/ene.13412.

    PMID: 28803444
  12. 12

    Diagnosing, monitoring and managing behavioural variant frontotemporal dementia.

    Piguet O, Kumfor F, Hodges J

    The Medical journal of Australia 2017; (207(7)):303-308 doi:10.5694/mja16.01458.

    PMID: 28954617
  13. 13

    The tailored activity program (TAP) to address behavioral disturbances in frontotemporal dementia: a feasibility and pilot study.

    O'Connor CM, Clemson L, Brodaty H, et al.

    Disability and rehabilitation 2019; (41(3)):299-310 doi:10.1080/09638288.2017.1387614.

    PMID: 29034719
  14. 14

    Frontotemporal dementia with trans-activation response DNA-binding protein 43 presenting with catatonic syndrome.

    Watanabe R, Kawakami I, Onaya M, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2018; (38(3)):281-287 doi:10.1111/neup.12442.

    PMID: 29110334
  15. 15

    The Genetics of Monogenic Frontotemporal Dementia.

    Takada LT

    Dementia & neuropsychologia 2015; (9(3)):219-229 doi:10.1590/1980-57642015DN93000003.

    PMID: 29213965
  16. 16

    Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.

    Liu S, Liu J, Wang XD, et al.

    International psychogeriatrics 2018; (30(8)):1131-1138 doi:10.1017/S1041610217002630.

    PMID: 29223171
  17. 17

    Anosognosia in degenerative brain diseases: The role of the right hemisphere and of its dominance for emotions.

    Gainotti G

    Brain and cognition 2018; (127()):13-22 doi:10.1016/j.bandc.2018.08.002.

    PMID: 30179807
  18. 18

    Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

    Bergeron D, Gorno-Tempini ML, Rabinovici GD, et al.

    Annals of neurology 2018; (84(5)):729-740 doi:10.1002/ana.25333.

    PMID: 30255971
  19. 19

    A Review: Mealtime Difficulties following Frontotemporal Lobar Degeneration.

    Lewis C, Walterfang M, Velakoulis D, Vogel AP

    Dementia and geriatric cognitive disorders 2018; (46(5-6)):285-297 doi:10.1159/000494210.

    PMID: 30423586
  20. 20

    Genetic screen in a large series of patients with primary progressive aphasia.

    Ramos EM, Dokuru DR, Van Berlo V, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2019; (15(4)):553-560 doi:10.1016/j.jalz.2018.10.009.

    PMID: 30599136
  21. 21

    Pharmacological Management of Dementia with Lewy Bodies.

    Hershey LA, Coleman-Jackson R

    Drugs & aging 2019; (36(4)):309-319 doi:10.1007/s40266-018-00636-7.

    PMID: 30680679
  22. 22

    More than words: Social cognition across variants of primary progressive aphasia.

    Fittipaldi S, Ibanez A, Baez S, et al.

    Neuroscience and biobehavioral reviews 2019; (100()):263-284 doi:10.1016/j.neubiorev.2019.02.020.

    PMID: 30876954
  23. 23

    A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia.

    Ash S, Nevler N, Phillips J, et al.

    Brain and language 2019; (194()):46-57 doi:10.1016/j.bandl.2019.04.006.

    PMID: 31075725
  24. 24

    Understanding Frontotemporal Disease Progression and Management Strategies.

    Mulkey M

    The Nursing clinics of North America 2019; (54(3)):437-448 doi:10.1016/j.cnur.2019.04.011.

    PMID: 31331629
  25. 25

    Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.

    Miyagawa T, Brushaber D, Syrjanen J, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):79-90 doi:10.1016/j.jalz.2019.05.013.

    PMID: 31477517
  26. 26

    New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.

    Boxer AL, Gold M, Feldman H, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):131-143 doi:10.1016/j.jalz.2019.06.4956.

    PMID: 31668596
  27. 27

    Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.

    van der Ende EL, Meeter LH, Poos JM, et al.

    The Lancet. Neurology 2019; (18(12)):1103-1111 doi:10.1016/S1474-4422(19)30354-0.

    PMID: 31701893
  28. 28

    When you hear hoofbeats, think horses and zebras: The importance of a wide differential when it comes to frontotemporal lobar degeneration.

    Nathani M, Jaleel V, Turner A, et al.

    Asian journal of psychiatry 2020; (47()):101875 doi:10.1016/j.ajp.2019.101875.

    PMID: 31775108
  29. 29

    Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.

    Jabbari E, Holland N, Chelban V, et al.

    JAMA neurology 2020; (77(3)):377-387 doi:10.1001/jamaneurol.2019.4347.

    PMID: 31860007
  30. 30

    Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.

    Miyagawa T, Brushaber D, Syrjanen J, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):106-117 doi:10.1002/alz.12033.

    PMID: 31914218
  31. 31

    Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

    Heuer HW, Wang P, Rascovsky K, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):60-70 doi:10.1002/alz.12046.

    PMID: 31914226
  32. 32

    Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

    Thijssen EH, La Joie R, Wolf A, et al.

    Nature medicine 2020; (26(3)):387-397 doi:10.1038/s41591-020-0762-2.

    PMID: 32123386
  33. 33

    The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.

    Karantali E, Kazis D, Chatzikonstantinou S, et al.

    Aging clinical and experimental research 2021; (33(4)):869-881 doi:10.1007/s40520-020-01554-8.

    PMID: 32306372
  34. 34

    Neuropsychiatric Aspects of Frontotemporal Dementia.

    Younes K, Miller BL

    The Psychiatric clinics of North America 2020; (43(2)):345-360 doi:10.1016/j.psc.2020.02.005.

    PMID: 32439026
  35. 35

    Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.

    Cajanus A, Katisko K, Kontkanen A, et al.

    Annals of clinical and translational neurology 2020; (7(6)):903-910 doi:10.1002/acn3.51041.

    PMID: 32441885
  36. 36

    Disease Progression in Frontotemporal Dementia and Alzheimer Disease: The Contribution of Staging Scales.

    Lima-Silva TB, Mioshi E, Bahia VS, et al.

    Journal of geriatric psychiatry and neurology 2021; (34(5)):397-404 doi:10.1177/0891988720944239.

    PMID: 32762416
  37. 37

    Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.

    Staffaroni AM, Goh SM, Cobigo Y, et al.

    JAMA network open 2020; (3(10)):e2022847 doi:10.1001/jamanetworkopen.2020.22847.

    PMID: 33112398
  38. 38

    Young-onset frontotemporal dementia with FUS pathology.

    Gowell M, Baker I, Ansorge O, Husain M

    Practical neurology 2020; doi:10.1136/practneurol-2020-002730.

    PMID: 33310885
  39. 39

    Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network.

    Leroy M, Bertoux M, Skrobala E, et al.

    Alzheimer's research & therapy 2021; (13(1)):19 doi:10.1186/s13195-020-00753-9.

    PMID: 33419472
  40. 40

    The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.

    Peet BT, Castro-Suarez S, Miller BL

    Advances in experimental medicine and biology 2021; (1281()):17-31 doi:10.1007/978-3-030-51140-1_2.

    PMID: 33433866
  41. 41

    Predictors of survival in frontotemporal lobar degeneration syndromes.

    El-Wahsh S, Finger EC, Piguet O, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-324349.

    PMID: 33441385
  42. 42

    Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.

    Altomare D, Caprioglio C, Assal F, et al.

    European journal of nuclear medicine and molecular imaging 2021; (48(7)):2200-2211 doi:10.1007/s00259-021-05246-x.

    PMID: 33638661
  43. 43

    Differential early subcortical involvement in genetic FTD within the GENFI cohort.

    Bocchetta M, Todd EG, Peakman G, et al.

    NeuroImage. Clinical 2021; (30()):102646 doi:10.1016/j.nicl.2021.102646.

    PMID: 33895632
  44. 44

    The natural history of primary progressive aphasia: beyond aphasia.

    Ulugut H, Stek S, Wagemans LEE, et al.

    Journal of neurology 2022; (269(3)):1375-1385 doi:10.1007/s00415-021-10689-1.

    PMID: 34216263
  45. 45

    Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries.

    Duran-Aniotz C, Orellana P, Leon Rodriguez T, et al.

    Frontiers in neurology 2021; (12()):663407 doi:10.3389/fneur.2021.663407.

    PMID: 34248820
  46. 46

    Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.

    Peet BT, Spina S, Mundada N, La Joie R

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; (18(2)):728-752 doi:10.1007/s13311-021-01101-x.

    PMID: 34389969
  47. 47

    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.

    Legaz A, Abrevaya S, Dottori M, et al.

    Brain : a journal of neurology 2022; (145(3)):1052-1068 doi:10.1093/brain/awab345.

    PMID: 34529034
  48. 48

    Behavioral and Cognitive Response to Selective Serotonin Reuptake Inhibitors in Frontotemporal Lobar Degeneration: A Systematic Review and Meta-analysis.

    Nisar M, Abubaker ZJ, Nizam MA, et al.

    Clinical neuropharmacology 2021; (44(5)):175-183 doi:10.1097/WNF.0000000000000469.

    PMID: 34542955
  49. 49

    Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review.

    Geraudie A, Battista P, García AM, et al.

    Neuroscience and biobehavioral reviews 2021; (131()):1076-1095 doi:10.1016/j.neubiorev.2021.10.015.

    PMID: 34673112
  50. 50

    In Vivo 18 F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.

    Zhou XY, Lu JY, Liu FT, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(3)):525-534 doi:10.1002/mds.28867.

    PMID: 34842301
  51. 51

    The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.

    Silverman HE, Ake JM, Manoochehri M, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2022; (18(9)):1635-1649 doi:10.1002/alz.12494.

    PMID: 34854532
  52. 52

    Diminished preparatory physiological responses in frontotemporal lobar degeneration syndromes.

    Chen KH, Hua AY, Toller G, et al.

    Brain communications 2022; (4(2)):fcac075 doi:10.1093/braincomms/fcac075.

    PMID: 35441132
  53. 53

    Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism.

    Jung NY, Park KH, Seo SW, et al.

    Journal of clinical medicine 2022; (11(8)) doi:10.3390/jcm11082260.

    PMID: 35456351
  54. 54

    Biological basis and psychiatric symptoms in frontotemporal dementia.

    Mori K, Ikeda M

    Psychiatry and clinical neurosciences 2022; (76(8)):351-360 doi:10.1111/pcn.13375.

    PMID: 35557018
  55. 55

    Advances in Treatment of Frontotemporal Dementia.

    Magrath Guimet N, Zapata-Restrepo LM, Miller BL

    The Journal of neuropsychiatry and clinical neurosciences 2022; (34(4)):316-327 doi:10.1176/appi.neuropsych.21060166.

    PMID: 35578801
  56. 56

    Behavioral Variant Frontotemporal Dementia.

    Boeve BF

    Continuum (Minneapolis, Minn.) 2022; (28(3)):702-725 doi:10.1212/CON.0000000000001105.

    PMID: 35678399
  57. 57

    Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia.

    Younes K, Borghesani V, Montembeault M, et al.

    Brain : a journal of neurology 2022; (145(11)):4080-4096 doi:10.1093/brain/awac217.

    PMID: 35731122
  58. 58

    Neuroimmune dysfunction in frontotemporal dementia: Insights from progranulin and C9orf72 deficiency.

    Hashimoto K, Jahan N, Miller ZA, Huang EJ

    Current opinion in neurobiology 2022; (76()):102599 doi:10.1016/j.conb.2022.102599.

    PMID: 35792478
  59. 59

    The CBI-R detects early behavioural impairment in genetic frontotemporal dementia.

    Nelson A, Russell LL, Peakman G, et al.

    Annals of clinical and translational neurology 2022; (9(5)):644-658 doi:10.1002/acn3.51544.

    PMID: 35950369
  60. 60

    The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration.

    Perry A, Hughes LE, Adams N, et al.

    Translational psychiatry 2022; (12(1)):348 doi:10.1038/s41398-022-02114-6.

    PMID: 36030249
  61. 61

    Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.

    Baiardi S, Quadalti C, Mammana A, et al.

    Alzheimer's research & therapy 2022; (14(1)):153 doi:10.1186/s13195-022-01093-6.

    PMID: 36221099
  62. 62

    White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers.

    Lee H, Mackenzie IRA, Beg MF, et al.

    Brain communications 2023; (5(1)):fcac333 doi:10.1093/braincomms/fcac333.

    PMID: 36632182
  63. 63

    Bilateral post-traumatic hygromas in patient with frontotemporal dementia.

    Scalia G, Marrone S, Costanzo R, et al.

    Surgical neurology international 2022; (13()):597 doi:10.25259/SNI_1056_2022.

    PMID: 36761258
  64. 64

    Behavioral variant frontotemporal dementia in patients with primary psychiatric disorder: A magnetic resonance imaging study.

    Tafuri B, Filardi M, Frisullo ME, et al.

    Brain and behavior 2023; (13(4)):e2896 doi:10.1002/brb3.2896.

    PMID: 36864745
  65. 65

    New Approaches to the Treatment of Frontotemporal Dementia.

    Neylan KD, Miller BL

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; (20(4)):1055-1065 doi:10.1007/s13311-023-01380-6.

    PMID: 37157041
  66. 66

    Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.

    Bede P, Lulé D, Müller HP, et al.

    Journal of neurology 2023; (270(9)):4235-4247 doi:10.1007/s00415-023-11764-5.

    PMID: 37178170
  67. 67

    Social Cognition in Behavioral Variant Frontotemporal Dementia and Pathological Subtypes: A Narrative Review.

    Dilcher R, Malpas CB, O'Brien TJ, Vivash L

    Journal of Alzheimer's disease : JAD 2023; (94(1)):19-38 doi:10.3233/JAD-221171.

    PMID: 37212100
  68. 68

    Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum.

    Zhang L, Flagan TM, Häkkinen S, et al.

    Annals of neurology 2023; (94(4)):632-646 doi:10.1002/ana.26738.

    PMID: 37431188
  69. 69

    Psychological and social impacts of frontotemporal dementia on caregivers and family members - A systematic review.

    Tan YL, Lo YKJ, Ho CSH

    General hospital psychiatry 2024; (86()):33-49 doi:10.1016/j.genhosppsych.2023.11.011.

    PMID: 38064912
  70. 70

    Palliative Care in Neuro-oncology.

    Besbris JM, Taylor LP

    Seminars in neurology 2024; (44(1)):26-35 doi:10.1055/s-0043-1777703.

    PMID: 38176423
  71. 71

    Progress in Primary Progressive Aphasia: A Review.

    Kertesz A, Finger E, Munoz DG

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2024; (37(1)):3-12 doi:10.1097/WNN.0000000000000365.

    PMID: 38498721
  72. 72

    Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration.

    Libri I, Altomare D, Bracca V, et al.

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2024; (32(8)):1004-1013 doi:10.1016/j.jagp.2024.03.002.

    PMID: 38521735
  73. 73

    Identifying and Addressing Functional Communication Challenges in Patients With Behavioral Variant Frontotemporal Dementia.

    Meade G, Machulda MM, Clark HM, et al.

    American journal of speech-language pathology 2024; (33(4)):1573-1589 doi:10.1044/2024_AJSLP-24-00013.

    PMID: 38843453
  74. 74

    Association of cortical morphology, white matter hyperintensity, and glymphatic function in frontotemporal dementia variants.

    Xiao D, Li J, Ren Z, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2024; (20(9)):6045-6059 doi:10.1002/alz.14158.

    PMID: 39129270
  75. 75

    Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes.

    Fieldhouse JLP, van Engelen ME, Handgraaf D, et al.

    European journal of neurology 2024; (31(12)):e16426 doi:10.1111/ene.16426.

    PMID: 39171655
  76. 76

    RAN Translation of C9orf72-Related Dipeptide Repeat Proteins in Zebrafish Recapitulates Hallmarks of Amyotrophic Lateral Sclerosis and Identifies Hypothermia as a Therapeutic Strategy.

    Burrows DJ, McGown A, Abduljabbar O, et al.

    Annals of neurology 2024; (96(6)):1058-1069 doi:10.1002/ana.27068.

    PMID: 39215697
  77. 77

    Genome-wide association study meta-analysis of neurofilament light (NfL) levels in blood reveals novel loci related to neurodegeneration.

    Ahmad S, Imtiaz MA, Mishra A, et al.

    Communications biology 2024; (7(1)):1103 doi:10.1038/s42003-024-06804-3.

    PMID: 39251807
  78. 78

    Treatment of Alzheimer Disease.

    Geldmacher DS

    Continuum (Minneapolis, Minn.) 2024; (30(6)):1823-1844 doi:10.1212/CON.0000000000001503.

    PMID: 39620846
  79. 79

    Musicality and social cognition in dementia: clinical and anatomical associations.

    van 't Hooft JJ, Hartog WL, Braun M, et al.

    Brain communications 2024; (6(6)):fcae429 doi:10.1093/braincomms/fcae429.

    PMID: 39678365
  80. 80

    Decoding TDP-43: the molecular chameleon of neurodegenerative diseases.

    Zeng J, Luo C, Jiang Y, et al.

    Acta neuropathologica communications 2024; (12(1)):205 doi:10.1186/s40478-024-01914-9.

    PMID: 39736783
  81. 81

    Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.

    Sheth U, Öijerstedt L, Heckman MG, et al.

    Molecular neurodegeneration 2025; (20(1)):30 doi:10.1186/s13024-025-00821-4.

    PMID: 40075459
  82. 82

    Elements of effective palliative care interventions in advanced heart failure: A narrative review.

    Allcroft P, De Pasquale CG, Lim D, et al.

    ESC heart failure 2025; (12(3)):1759-1775 doi:10.1002/ehf2.15243.

    PMID: 40108827
  83. 83

    Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.

    Doecke JD, Bellomo G, Vermunt L, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2025; (21(6)):e14573 doi:10.1002/alz.14573.

    PMID: 40551285
  84. 84

    Survival rates in frontotemporal dementia and Alzheimer's disease.

    Foxe D, Muggleton J, Cheung SC, et al.

    Neurodegenerative disease management 2025; (15(5)):191-197 doi:10.1080/17582024.2025.2527553.

    PMID: 40600814
  85. 85

    Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome.

    Murakami A, Koga S, Sekiya H, et al.

    Acta neuropathologica communications 2025; (13(1)):151 doi:10.1186/s40478-025-02058-0.

    PMID: 40635087
  86. 86

    Progressive Supranuclear Palsy and Corticobasal Syndrome.

    McFarland NR

    Continuum (Minneapolis, Minn.) 2025; (31(4)):1023-1049 doi:10.1212/cont.0000000000001607.

    PMID: 40748119
  87. 87

    Language and psychiatric symptom overlap in FTD: an SLP perspective.

    Masson-Trottier M

    International review of psychiatry (Abingdon, England) 2025; (37(8)):781-794 doi:10.1080/09540261.2025.2583258.

    PMID: 41208381
  88. 88

    The Impact of Caring on Psychological Wellbeing: A Qualitative Study in Carers of People Living With Behavioural-Variant Frontotemporal Dementia.

    Ocampo IM, Todd J, Wei G, Kumfor F

    Journal of geriatric psychiatry and neurology 2026; (39(4)):534-548 doi:10.1177/08919887251401262.

    PMID: 41271195
  89. 89

    Second-generation antipsychotics - Cardiac ion channel modulation and QT interval disturbances: A review.

    Erkan O, Dai AS, Ozturk N, Ozdemir S

    Biomolecules & biomedicine 2025; (26(6)):895-911 doi:10.17305/bb.2025.13405.

    PMID: 41376506
  90. 90

    A Review of Dementia Caregiver Interventions: Valuing Psychological Well-Being and Economic Impact Through the State-Preference Method.

    Consiglio A, Lopez A, Bosco A

    International journal of environmental research and public health 2026; (23(1)) doi:10.3390/ijerph23010104.

    PMID: 41595898
  91. 91

    Timing and outcomes of outpatient palliative care consultations in advanced cancer.

    Torres-Tenor JL, Bruera E, Ortí-Hortelano MJ, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04276-x.

    PMID: 41758445